Tejal Vakharia
Net Worth
Last updated:
What is Tejal Vakharia net worth?
The estimated net worth of Ms. Tejal Vakharia is at least $2,409,097 as of 12 Dec 2022. She has earned $518,437 from insider trading and has received compensation worth at least $1,890,660 in Veradigm Inc..
What is the salary of Tejal Vakharia?
Ms. Tejal Vakharia salary is $630,220 per year as Senior Vice President and Gen. Counsel of Marketing & Gov. Affairs in Veradigm Inc..
How old is Tejal Vakharia?
Ms. Tejal Vakharia is 52 years old, born in 1973.
What stocks does Tejal Vakharia currently own?
As insider, Ms. Tejal Vakharia owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Veradigm Inc. (MDRX) | Senior Vice President and Gen. Counsel of Marketing & Gov. Affairs | 222,604 | $0 | $0 |
What does Veradigm Inc. do?
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising Practice Management software, AI Patient Scheduling Software, and Electronic Statements and Payments; revenue cycle management solutions, including Revenue Cycle Services and revenue cycle management clearinghouse; electronic health records solutions, which include ePrescribe with EPCS, EHR software, Veradigm HER, and Practice Fusion HER; and Patient Engagement Platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as Veradigm Connect, Veradigm App Expo, and Diagnostic Ordering and Resulting Network; Channel Partner Program; and Veradigm ePrescribe Enterprise. In addition, the company offers solutions to health plans and payers, comprising risk adjustment solutions, such as Health Equity Analytics, Risk Adjustment Analytics, Risk Mitigator, Comprehensive Submissions, and Utilization Analytics; quality management solutions, which include quality analytics and risk adjustment and quality management; data exchange+coding solutions, including eChart Courier, eChart Coder, and eChart Integration and Analytics; provider engagement and Veradigm Payer Insights; and Veradigm Payerpath solutions. Further, it provides solutions to biophama, including real world data solutions, such as real world and health data sets and cardiology and metabolic registries; real world evidence and Real World Evidence Analytics Platform; therapy focused solutions, such as cardiovascular, central nervous system, metabolic, and immunology data; and Digital Health Media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Tejal Vakharia insider trading
Veradigm Inc.
Ms. Tejal Vakharia has made 2 insider trades in 2022, according to the Form 4 filled with the SEC. Most recently she sold 8,642 units of MDRX stock worth $159,194 on 12 Dec 2022.
The largest trade she's ever made was exercising 19,793 units of MDRX stock on 10 Nov 2022. As of 12 Dec 2022 she still owns at least 222,604 units of MDRX stock.
Veradigm key executives
Veradigm Inc. executives and other stock owners filed with the SEC:
- Mr. Paul M. Black (67) Chief Executive Officer & Director
- Mr. Richard J. Poulton (60) Pres & Chief Financial Officer
- Ms. Tejal Vakharia (52) Senior Vice President and Gen. Counsel of Marketing & Gov. Affairs